CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- SC 13G Stake Amended Statement of Ownership
- 4 Option exercise Director acquired 17,500 shares (option exercise)
- 4 Open-market sale CFO and VP, Corp. Development sold 8,711 shares at an average $17.18 ($149,627)
- 4 Open-market sale Director sold 22,500 shares at $16.83 ($378,693)
- 8-K Event Agreement ended
- 4 Open-market sale CFO and VP, Corp. Development sold 15,625 shares at $16.81 ($262,656)
- 4 Open-market sale Director sold 8,500 shares at $17.75 ($150,908)
- CT ORDER Other Confidential Order
- 4 Open-market sale CFO and VP, Corp. Development sold 15,000 shares at $15.90 ($238,500)
- 4 Open-market sale President and CEO sold 50,000 shares at $15.39 ($769,500)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale CFO and VP, Corp. Development sold 15,000 shares at $12.65 ($189,750)
- 4 Open-market sale President and CEO sold 75,000 shares at $15.02 ($1,126,500)
- 4 Open-market sale CFO and VP, Corp. Development sold 15,000 shares at $12.35 ($185,250)
Page 34 of 86 · 1,717 filings